Medical Devices - Surgical Instruments & OEM Supply
Strategic Profile
The company also provides engineering, quality, and regulatory consulting services and manufactures and sells rotary air motors to various industries. This diversified service model combined with specialized manufacturing creates sticky relationships with medical device OEMs. Pro-Dex operates in a niche but high-margin market segment with growing demand from orthopedic and minimally invasive surgery trends.
Cyborg Score Rationale
In 2025, Pro-Dex's revenue was $66.59 million, an increase of 23.68% compared to the previous year's $53.84 million, with earnings increasing 322.10%. Strong profitability and double-digit revenue growth demonstrate operational execution. The company faces normal market volatility but maintains solid fundamentals.
Top Insights
Strong earnings acceleration: net income grew 322% in fiscal 2025 despite revenue growing 24%, indicating improving operational leverage and margin expansion
Analyst support: one analyst rating is "Strong Buy" with $56.0 price target, suggesting significant upside from ~$43 current levels
Volatile equity story: experienced significant stock volatility with recent pullbacks presenting entry opportunities for thesis believers
Diversified revenue streams: consulting services and industrial air motor sales provide stability beyond core surgical instrument business
Named Competitors
Powered Surgical Instruments — Large diversified surgical equipment manufacturer
Surgical Power Tools — Major orthopedic device manufacturer with surgical tools